Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.

Purpose: Radiotherapy (RT) is a common treatment of head-and-neck carcinoma. The objective of this study was to perform a prospective multivariate assessment of the dose-effect relationship between intensity-modulated RT and hearing loss.

Methods And Materials: Pure tone audiometry at 0.